Contributions of Saccharomyces cerevisiae to Understanding Mammalian Gene Function and Therapy

Methods in Molecular Biology

Volumn 759, Issue , 2011, Pages 501-523

  Zhang, Nianshu ^a   Bilsland, Elizabeth ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

chemogenomic profiling; conservation and divergence; drug screening; drug targets; Functional complementation; interactome

Indexed keywords

FUNGAL PROTEIN;

ANIMAL; ARTICLE; BIOLOGY; BIOSYNTHESIS; DRUG DEVELOPMENT; GENETICS; HUMAN; MAMMAL; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; SACCHAROMYCES CEREVISIAE;

ANIMALS; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; FUNGAL PROTEINS; HUMANS; MAMMALS; MOLECULAR SEQUENCE ANNOTATION; SACCHAROMYCES CEREVISIAE;

EUKARYOTA; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 80054727613     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-173-4_28     Document Type: Chapter

References (152)

1. Dolinski, K., and Botstein, D. (2007) Orthology and functional conservation in eukaryotes. Annu. Rev. Genet. 41, 465–507.
2. Kataoka, T., Powers, S., Cameron, S., et al. (1985) Functional homology of mammalian and yeast RAS genes. Cell 40, 19–26.
3. Lee, M. G., and Nurse, P. (1987) Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 327, 31–35.
4. Goffeau, A., Barrell, B. G., Bussey, H., et al. (1996) Life with 6000 genes. Science 274, 546, 563–567.
5. Suter, B., Auerbach, D., and Stagljar, I. (2006) Yeast-based functional genomics and proteomics technologies: the first 15 years and beyond. Biotechniques 40, 625–644.
6. Winzeler, E. A., Shoemaker, D. D., Astro-moff, A., et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285, 901–906.
7. Hillenmeyer, M. E., Fung, E., Wildenhain, J., et al. (2008) The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320, 362–365.
8. Giaever, G., Chu, A. M., Ni, L., et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387–391.
9. Deutschbauer, A. M., Jaramillo, D. F., Proctor, M., et al. (2005) Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 169, 1915–1925.
10. Mager, W. H., and Winderickx, J. (2005) Yeast as a model for medical and medicinal research. Trends Pharmacol. Sci. 26, 265–273.
11. Oliver, S. G. (2006) From genomes to systems: the path with yeast. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361, 477–482.
12. Liolios, K., Tavernarakis, N., Hugenholtz, P., and Kyrpides, N. C. (2006) The genomes on line database (GOLD) v.2: a monitor of genome projects worldwide. Nucleic Acids Res. 34, D332–D334.
13. Lee, D., Redfern, O., and Orengo, C. (2007) Predicting protein function from sequence and structure. Nat. Rev. Mol. Cell Biol. 8, 995–1005.
14. Velours, J., Vaillier, J., Paumard, P., Souban-nier, V., Lai-Zhang, J., and Mueller, D. M. (2001) Bovine coupling factor 6, with just 14.5% shared identity, replaces subunit h in the yeast ATP synthase. J. Biol. Chem. 276, 8602–8607.
15. Dann, S. G., Selvaraj, A., and Thomas, G. (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13, 252–259.
16. Sobko, A. (2006) Systems biology of AGC kinases in fungi. Sci. STKE 2006, re9.
17. Urban, J., Soulard, A., Huber, A., et al. (2007) Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol. Cell 26, 663–674.
18. Oliver, S. G., van der Aart, Q. J., Agostoni-Carbone, M. L., et al. (1992) The complete DNA sequence of yeast chromosome III. Nature 357, 38–46.
19. Ouzounis, C., and Sander, C. (1993) Homology of the NifS family of proteins to a new class of pyridoxal phosphate-dependent enzymes. FEBS Lett. 322, 159–164.
20. Gross, S., and Moore, C. (2001) Five subunits are required for reconstitution of the cleavage and polyadenylation activities of Saccharomyces cerevisiae cleavage factor I. Proc. Natl. Acad. Sci. USA 98, 6080–6085.
21. ′-kinase (hClp1) can function as a tRNA splicing enzyme in vivo. RNA 14, 1737–1745.
22. Hartwell, L. H. (2004) Yeast and cancer. Biosci. Rep. 24, 523–544.
23. Grunewald, S., Matthijs, G., and Jaeken, J. (2002) Congenital disorders of glycosylation: a review. Pediatr. Res. 52, 618–624.
24. Zeviani, M., and Carelli, V. (2007) Mitochondrial disorders. Curr. Opin. Neurol. 20, 564–571.
25. Botstein, D., Chervitz, S. A., and Cherry, J. M. (1997) Yeast as a model organism. Science 277, 1259–1260.
26. Ooi, S. L., Pan, X., Peyser, B. D., et al. (2006) Global synthetic-lethality analysis and yeast functional profiling. Trends Genet. 22, 56–63.
27. Zhang, N., Osborn, M., Gitsham, P., Yen, K., Miller, J. R., and Oliver, S. G. (2003) Using yeast to place human genes in functional categories. Gene 303, 121–129.
28. Wishart, J. A., Hayes, A., Wardleworth, L., Zhang, N., and Oliver, S. G. (2005) Doxy-cycline, the drug used to control the tet- regulatable promoter system, has no effect on global gene expression in Saccharomyces cerevisiae. Yeast 22, 565–569.
29. Mnaimneh, S., Davierwala, A. P., Haynes, J., et al. (2004) Exploration of essential gene functions via titratable promoter alleles. Cell 118, 31–44.
30. Kanemaki, M., Sanchez-Diaz, A., Gambus, A., and Labib, K. (2003) Functional proteomic identification of DNA replication proteins by induced proteolysis in vivo. Nature 423, 720–724.
31. Sanchez-Diaz, A., Kanemaki, M., March-esi, V., and Labib, K. (2004) Rapid depletion of budding yeast proteins by fusion to a heat-inducible degron. Sci. STKE 2004, PL8.
32. Terziyska, N., Grumbt, B., Kozany, C., and Hell, K. (2009) Structural and functional roles of the conserved cysteine residues of the redox-regulated import receptor Mia40 in the intermembrane space of mitochondria. J. Biol. Chem. 284, 1353–1363.
33. Han, G. S., Sreenivas, A., Choi, M. G., et al. (2005) Expression of Human CTP synthetase in Saccharomyces cerevisiae reveals phosphorylation by protein kinase A. J. Biol. Chem. 280, 38328–38336.
34. Sharma, S., Sommers, J. A., and Brosh, R. M., Jr. (2004) In vivo function of the conserved non-catalytic domain of Werner syndrome helicase in DNA replication. Hum. Mol. Genet. 13, 2247–2261.
35. Aller, S. G., Eng, E. T., De Feo, C. J., and Unger, V. M. (2004) Eukaryotic CTR copper uptake transporters require two faces of the third transmembrane domain for helix packing, oligomerization, and function. J. Biol. Chem. 279, 53435–53441.
36. Grillari, J., Ajuh, P., Stadler, G., et al. (2005) SNEV is an evolutionarily conserved splicing factor whose oligomerization is necessary for spliceosome assembly. Nucleic Acids Res. 33, 6868–6883.
37. Boocock, G. R., Marit, M. R., and Rom-mens, J. M. (2006) Phylogeny, sequence conservation, and functional complementation of the SBDS protein family. Genomics 87, 758–771.
38. Chang, C. P., Lin, G., Chen, S. J., Chiu, W. C., Chen, W. H., and Wang, C. C. (2008) Promoting the formation of an active syn-thetase/tRNA complex by a nonspecific tRNA-binding domain. J. Biol. Chem. 283, 30699–30706.
39. Vaz, F. M., Houtkooper, R. H., Valian-pour, F., Barth, P. G., and Wanders, R. J. (2003) Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism. J. Biol. Chem. 278, 43089–43094.
40. Ma, L., Vaz, F. M., Gu, Z., Wanders, R. J., and Greenberg, M. L. (2004) The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome. J. Biol. Chem. 279, 44394–44399.
41. Tabuchi, M., Tanaka, N., Nishida-Kitayama, J., Ohno, H., and Kishi, F. (2002) Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol. Biol. Cell 13, 4371–4387.
42. De Marcos Lousa, C., Trezeguet, V., Dianoux, A. C., Brandolin, G., and Lauquin, G. J. (2002) The human mitochondrial ADP/ATP carriers: kinetic properties and biogenesis of wild-type and mutant proteins in the yeast S. cerevisiae. Biochemistry 41, 14412–14420.
43. Zhang, Y., and Spremulli, L. L. (1998) Identification and cloning of human mitochondrial translational release factor 1 and the ribosome recycling factor. Biochim. Biophys. Acta 1443, 245–250.
44. Soleimanpour-Lichaei, H. R., Kuhl, I., Gaisne, M., et al. (2007) mtRF1a is a human mitochondrial translation release factor decoding the major termination codons UAA and UAG. Mol. Cell 27, 745–757.
45. Tamburini, B. A., Carson, J. J., Adkins, M. W., and Tyler, J. K. (2005) Functional conservation and specialization among eukaryotic anti-silencing function 1 histone chaperones. Eukaryot. Cell 4, 1583–1590.
46. Chiron, S., Suleau, A., and Bonnefoy, N. (2005) Mitochondrial translation: elongation factor tu is essential in fission yeast and depends on an exchange factor conserved in humans but not in budding yeast. Genetics 169, 1891–1901.
47. St-Pierre, B., Liu, X., Kha, L. C., et al. (2005) Conserved and specific functions of mammalian ssu72. Nucleic Acids Res. 33, 464–477.
48. Gao, X. D., Tachikawa, H., Sato, T., Jigami, Y., and Dean, N. (2005) Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine trans-ferase required for the second step of N-linked glycosylation. J. Biol. Chem. 280, 36254–36262.
49. Ozanick, S., Krecic, A., Andersland, J., and Anderson, J. T. (2005) The bipartite structure of the tRNA m1A58 methyltransferase from S. cerevisiae is conserved in humans. RNA 11, 1281–1290.
50. Otto, H., Conz, C., Maier, P., et al. (2005) The chaperones MPP11 and Hsp70L1 form the mammalian ribosome-associated complex. Proc. Natl. Acad. Sci. USA 102, 10064–10069.
51. Proshkina, G. M., Shematorova, E. K., Proshkin, S. A., Zaros, C., Thuriaux, P., and Shpakovski, G. V. (2006) Ancient origin, functional conservation and fast evolution of DNA-dependent RNA polymerase III. Nucleic Acids Res. 34, 3615–3624.
52. Loewith, R., Jacinto, E., Wullschleger, S., et al. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457–468.
53. Wullschleger, S., Loewith, R., and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471–484.
54. De Virgilio, C., and Loewith, R. (2006) Cell growth control: little eukaryotes make big contributions. Oncogene 25, 6392–6415.
55. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P., and Guan, K. L. (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935–945.
56. Berger, A. C., Vanderford, T. H., Gernert, K. M., Nichols, J. W., Faundez, V., and Corbett, A. H. (2005) Saccharomyces cerevisiae Npc2p is a functionally conserved homologue of the human Niemann-Pick disease type C 2 protein, hNPC2. Eukaryot. Cell 4, 1851–1862.
57. Binda, M., Peli-Gulli, M. P., Bonfils, G., et al. (2009) The Vam6 GEF controls TORC1 by activating the EGO complex. Mol. Cell 35, 563–573.
58. Sancak, Y., Peterson, T. R., Shaul, Y. D., et al. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496–1501.
59. Wieland, G., Orthaus, S., Ohndorf, S., Diekmann, S., and Hemmerich, P. (2004) Functional complementation of human cen-tromere protein A (CENP-A) by Cse4p from Saccharomyces cerevisiae. Mol. Cell Biol. 24, 6620–6630.
60. Ricardo, S., and Lehmann, R. (2009) An ABC transporter controls export of a Drosophila germ cell attractant. Science 323, 943–946.
61. Wells, J. A., and McClendon, C. L. (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001–1009.
62. Fields, S., and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245–246.
63. Fromont-Racine, M., Rain, J. C., and Legrain, P. (1997) Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet. 16, 277–282.
64. Walhout, A. J., Temple, G. F., Brasch, M. A., et al. (2000) GATEWAY recombina-tional cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol. 328, 575–592.
65. Uetz, P., Giot, L., Cagney, G., et al. (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403, 623–627.
66. Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M., and Sakaki, Y. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA 98, 4569–4574.
67. Mackay, J. P., Sunde, M., Lowry, J. A., Crossley, M., and Matthews, J. M. (2007) Protein interactions: is seeing believing? Trends Biochem. Sci. 32, 530–531.
68. von Mering, C., Krause, R., Snel, B., et al. (2002) Comparative assessment of large-scale data sets of protein-protein interactions. Nature 417, 399–403.
69. Yu, H., Braun, P., Yildirim, M. A., et al. (2008) High-quality binary protein interaction map of the yeast interactome network. Science 322, 104–110.
70. Gavin, A. C., Aloy, P., Grandi, P., et al. (2006) Proteome survey reveals modularity of the yeast cell machinery. Nature 440, 631–636.
71. Krogan, N. J., Cagney, G., Yu, H., et al. (2006) Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440, 637–643.
72. Tarassov, K., Messier, V., Landry, C. R., et al. (2008) An in vivo map of the yeast protein interactome. Science 320, 1465– 1470.
73. Cusick, M. E., Klitgord, N., Vidal, M., and Hill, D. E. (2005) Interactome: gateway into systems biology. Hum. Mol. Genet. 14(Spec No. 2), R171-R181.
74. Levy, E. D., Landry, C. R., and Michnick, S. W. (2009) How perfect can protein interactomes be? Sci. Signal. 2, pe11.
75. LaCount, D. J., Vignali, M., Chettier, R., et al. (2005) A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 438, 103–107.
76. Li, S., Armstrong, C. M., Bertin, N., et al. (2004) A map of the interactome network of the metazoan C. elegans. Science 303, 540–543.
77. Simonis, N., Rual, J. F., Carvunis, A. R., et al. (2009) Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat. Methods 6, 47–54.
78. Giot, L., Bader, J. S., Brouwer, C., et al. (2003) A protein interaction map of Drosophila melanogaster. Science 302, 1727–1736.
79. Rual, J. F., Venkatesan, K., Hao, T., et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437, 1173–1178.
80. Stelzl, U., Worm, U., Lalowski, M., et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122, 957–968.
81. Venkatesan, K., Rual, J. F., Vazquez, A., et al. (2009) An empirical framework for binary interactome mapping. Nat. Methods 6, 83–90.
82. Bailer, S. M., and Haas, J. (2009) Connecting viral with cellular interactomes. Curr. Opin. Microbiol. 12, 453–459.
83. Boxem, M., Maliga, Z., Klitgord, N., et al. (2008) A protein domain-based interactome network for C. elegans early embryogenesis. Cell 134, 534–545.
84. Markson, G., Kiel, C., Hyde, R., et al. (2009) Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res. 19, 1905–1911.
85. Lim, J., Hao, T., Shaw, C., et al. (2006) A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125, 801–814.
86. Ideker, T., and Sharan, R. (2008) Protein networks in disease. Genome Res. 18, 644–52.
87. Hopkins, A. L., and Groom, C. R. (2002) The druggable genome. Nat. Rev. Drug Discov. 1, 727–730.
88. Cochran, A. G. (2000) Antagonists of protein-protein interactions. Chem. Biol. 7, R85–R94.
89. Domling, A. (2008) Small molecular weight protein-protein interaction antagonists: an insurmountable challenge? Curr. Opin. Chem. Biol. 12, 281–291.
90. Colas, P. (2008) High-throughput screening assays to discover small-molecule inhibitors of protein interactions. Curr. Drug Discov. Technol. 5, 190–199.
91. Bharucha, N., and Kumar, A. (2007) Yeast genomics and drug target identification. Comb. Chem. High Throughput Screen. 10, 618–634.
92. Hoon, S., St. Onge, R. P., Giaever, G., and Nislow, C. (2008) Yeast chemical genomics and drug discovery: an update. Trends Pharmacol. Sci. 29, 499–504.
93. Giaever, G., Shoemaker, D. D., Jones, T. W., et al. (1999) Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 21, 278–283.
94. Yan, Z., Costanzo, M., Heisler, L. E., et al. (2008) Yeast Barcoders: a chemogenomic application of a universal donor-strain collection carrying bar-code identifiers. Nat. Methods 5, 719–725.
95. Ho, C. H., Magtanong, L., Barker, S. L., et al. (2009) A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat. Biotechnol. 27, 369–377.
96. Parsons, A. B., Brost, R. L., Ding, H., et al. (2004) Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22, 62–69.
97. Yu, L., Lopez, A., Anaflous, A., et al. (2008) Chemical-genetic profiling of imidazo [1,2-a]pyridines and-pyrimidines reveals target pathways conserved between yeast and human cells. PLoS Genet. 4, e1000284.
98. Rine, J., Hansen, W., Hardeman, E., and Davis, R. W. (1983) Targeted selection of recombinant clones through gene dosage effects. Proc. Natl. Acad. Sci. USA 80, 6750–6754.
99. Armour, C. D., and Lum, P. Y. (2005) From drug to protein: using yeast genetics for high-throughput target discovery. Curr. Opin. Chem. Biol. 9, 20–24.
100. Giaever, G. (2003) A chemical genomics approach to understanding drug action. Trends Pharmacol. Sci. 24, 444–446.
101. Khozoie, C., Pleass, R. J., and Avery, S. V. (2009) The antimalarial drug quinine disrupts Tat2p-mediated tryptophan transport and causes tryptophan starvation. J. Biol. Chem. 284, 17968–17974.
102. Li, W., Mo, W., Shen, D., et al. (2005) Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet. 1, e36.
103. McCue, P. P., and Phang, J. M. (2008) Identification of human intracellular targets of the medicinal Herb St. John’s Wort by chemical-genetic profiling in yeast. J. Agric. Food Chem. 56, 11011–11017.
104. Ericson, E., Gebbia, M., Heisler, L. E., et al. (2008) Off-target effects of psychoac- tive drugs revealed by genome-wide assays in yeast. PLoS Genet. 4, e1000151.
105. Lesser, C. F., and Miller, S. I. (2001) Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J. 20, 1840–1849.
106. Siggers, K. A., and Lesser, C. F. (2008) The yeast Saccharomyces cerevisiae: a versatile model system for the identification and characterization of bacterial virulence proteins. Cell Host Microbe 4, 8–15.
107. Curak, J., Rohde, J., and Stagljar, I. (2009) Yeast as a tool to study bacterial effectors. Curr. Opin. Microbiol. 12, 18–23.
108. Zhang, M., Liang, Y., Zhang, X., Xu, Y., Dai, H., and Xiao, W. (2008) Deletion of yeast CWP genes enhances cell permeability to genotoxic agents. Toxicol. Sci. 103, 68–76.
109. King, K., Dohlman, H. G., Thorner, J., Caron, M. G., and Lefkowitz, R. J. (1990) Control of yeast mating signal transduction by a mammalian beta 2-adrenergic receptor and Gs alpha subunit. Science 250, 121–123.
110. Duport, C., Loeper, J., and Strosberg, A. D. (2003) Comparative expression of the human beta(2) and beta(3) adrenergic receptors in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1629, 34–43.
111. Sander, P., Grunewald, S., Maul, G., Rei-lander, H., and Michel, H. (1994) Constitutive expression of the human D2S-dopamine receptor in the unicellular yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta 1193, 255–262.
112. Dirnberger, D., and Seuwen, K. (2007) Signaling of human frizzled receptors to the mating pathway in yeast. PLoS One 2, e954.
113. Wedekind, A., O’Malley, M. A., Niebauer, R. T., and Robinson, A. S. (2006) Optimization of the human adenosine A2a receptor yields in Saccharomyces cerevisiae. Biotechnol. Prog. 22, 1249–1255.
114. Evans, B. J., Wang, Z., Broach, J. R., Oishi, S., Fujii, N., and Peiper, S. C. (2009) Expression of CXCR4, a n-coupled receptor for CXCL12 in yeast identification of new-generation inverse agonists. Methods Enzymol. 460, 399–412.
115. Brown, A. J., Dyos, S. L., Whiteway, M. S., et al. (2000) Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein alpha-subunit chimeras. Yeast 16, 11–22.
116. Dowell, S. J., and Brown, A. J. (2009) Yeast assays for G protein-coupled receptors. Methods Mol. Biol. 552, 213–229.
117. Ladds, G., Davis, K., Hillhouse, E. W., and Davey, J. (2003) Modified yeast cells to investigate the coupling of G protein-coupled receptors to specific G proteins. Mol. Microbiol. 47, 781–792.
118. Niebauer, R. T., and Robinson, A. S. (2006) Exceptional total and functional yields of the human adenosine (A2a) receptor expressed in the yeast Saccharomyces cerevisiae. Protein Expr. Purif. 46, 204–211.
119. Monk, B. C., and Cannon, R. D. (2002) Genomic pathways to antifungal discovery. Curr. Drug Targets Infect. Disord. 2, 309–329.
120. Ma, D. (2001) Applications of yeast in drug discovery. Prog. Drug Res. 57, 117–162.
121. Agarwal, A. K., Xu, T., Jacob, M. R., et al. (2008) Genomic and genetic approaches for the identification of antifungal drug targets. Infect. Disord. Drug Targets 8, 2–15.
122. De Backer, M. D., and Van Dijck, P. (2003) Progress in functional genomics approaches to antifungal drug target discovery. Trends Microbiol. 11, 470–478.
123. Balliano, G., Dehmlow, H., Oliaro-Bosso, S., et al. (2009) Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents. Bioorg. Med. Chem. Lett. 19, 718–723.
124. Kim, Y. U., Ashida, H., Mori, K., Maeda, Y., Hong, Y., and Kinoshita, T. (2007) Both mammalian PIG-M and PIG-X are required for growth of GPI14-disrupted yeast. J. Biochem. 142, 123–129.
125. Palmer, G., Louvion, J. F., Tibbetts, R. S., Engman, D. M., and Picard, D. (1995) Trypanosoma cruzi heat-shock protein 90 can functionally complement yeast. Mol. Biochem. Parasitol. 70, 199–202.
126. Papageorgiou, I., De Koning, H. P., Soteriadou, K., and Diallinas, G. (2008) Kinetic and mutational analysis of the Trypanosoma brucei NBT1 nucleobase transporter expressed in Saccharomyces cerevisiae reveals structural similarities between ENT and MFS transporters. Int. J. Parasitol. 38, 641–653.
127. Aguiar, P. H., Santos, D. N., Lobo, F. P., et al. (2006) Functional complementation of a yeast knockout strain by Schistosoma mansoni Rho1 GTPase in the presence of caffeine, an agent that affects mutants defective in the protein kinase C signal transduction pathway. Mem. Inst. Oswaldo Cruz 101(Suppl 1), 323–326.
128. Santos, D. N., Aguiar, P. H., Lobo, F. P., et al. (2007) Schistosoma mansoni: Heterologous complementation of a yeast null mutant by SmRbx, a protein similar to a RING box protein involved in ubiquitina-tion. Exp. Parasitol. 116, 440–449.
129. Aruna, K., Chakraborty, T., Rao, P. N., Santos, C., Ballesta, J. P., and Sharma, S. (2005) Functional complementation of yeast ribosomal P0 protein with Plasmodium falciparum P0. Gene 357, 9–17.
130. Djapa, L. Y., Basco, L. K., Zelikson, R., et al. (2007) Antifolate screening using yeast expressing Plasmodium vivax dihydro-folate reductase and in vitro drug susceptibility assay for Plasmodium falciparum. Mol. Biochem. Parasitol. 156, 89–92.
131. Shams-Eldin, H., Azzouz, N., Kedees, M. H., Orlean, P., Kinoshita, T., and Schwarz, R. T. (2002) The GPI1 homologue from Plasmodium falciparum complements a Saccharomyces cerevisiae GPI1 anchoring mutant. Mol. Biochem. Parasitol. 120, 73–81.
132. Wider, D., Peli-Gulli, M. P., Briand, P. A., Tatu, U., and Picard, D. (2009) The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities. Mol. Biochem. Parasitol. 164, 147–152.
133. Birkholtz, L. M., Blatch, G., Coetzer, T. L., et al. (2008) Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar. J. 7, 197.
134. LaCount, D. J., Schoenfeld, L. W., and Fields, S. (2009) Selection of yeast strains with enhanced expression of Plasmodium falciparum proteins. Mol. Biochem. Parasitol. 163, 119–122.
135. Liu, R., Lin, Q., Sun, Y., et al. (2009) Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris. Appl. Biochem. Biotechnol. 158, 432–444.
136. Bazan, S. B., de Alencar Muniz Chaves, A., Aires, K. A., Cianciarullo, A. M., Garcea, R. L., and Ho, P. L. (2009) Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. Arch. Virol. 154, 1609–1617.
137. Woo, M. K., An, J. M., Kim, J. D., Park, S. N., and Kim, H. J. (2008) Expression and purification of human papillomavirus 18 L1 virus-like particle from Saccharomyces cerevisiae. Arch. Pharm. Res. 31, 205–209.
138. Etemad, B., Batra, G., Raut, et al. (2008) An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. Am. J. Trop. Med. Hyg. 79, 353–363.
139. Gerngross, T. U. (2004) Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol. 22, 1409–1414.
140. Akeboshi, H., Chiba, Y., Kasahara, Y., et al. (2007) Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methy-lotrophic yeast Ogataea minuta. Appl. Environ. Microbiol. 73, 4805–4812.
141. Chen, Y., Jin, M., Egborge, T., Coppola, G., Andre, J., and Calhoun, D. H. (2000) Expression and characterization of glyco-sylated and catalytically active recombinant human alpha-galactosidase A produced in Pichia pastoris. Protein Expr. Purif. 20, 472–484.
142. Chiba, Y., Sakuraba, H., Kotani, M., et al. (2002) Production in yeast of alpha-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease. Glycobiology 12, 821–828.
143. Sakuraba, H., Chiba, Y., Kotani, M., et al. (2006) Corrective effect on Fabry mice of yeast recombinant human alpha-galactosidase with N-linked sugar chains suitable for lysosomal delivery. J. Hum. Genet. 51, 341–352.
144. Chiba, Y., and Akeboshi, H. (2009) Glycan engineering and production of ’humanized’ glycoprotein in yeast cells. Biol. Pharm. Bull. 32, 786–795.
145. Abe, H., Takaoka, Y., Chiba, Y., et al. (2009) Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins. Glycobiology 19, 428–436.
146. Graf, A., Dragosits, M., Gasser, B., and Mattanovich, D. (2009) Yeast systems biotechnology for the production of heterologous proteins. FEMS Yeast Res. 9, 335–348.
147. Hamilton, S. R., and Gerngross, T. U. (2007) Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr. Opin. Biotechnol. 18, 387–392.
148. Rakestraw, J. A., Sazinsky, S. L., Piatesi, A., Antipov, E., and Wittrup, K. D. (2009) Directed evolution of a secretory leader for the improved expression of heterologous proteins and full-length antibodies in Saccharomyces cerevisiae. Biotechnol. Bioeng. 103, 1192–1201.
149. Schirrmann, T., Al-Halabi, L., Dubel, S., and Hust, M. (2008) Production systems for recombinant antibodies. Front. Biosci. 13, 4576–4594.
150. Takegawa, K., Tohda, H., Sasaki, M., et al. (2009) Production of heterologous proteins using the fission-yeast (Schizosaccha-romyces pombe) expression system. Biotechnol. Appl. Biochem. 53, 227–235.
151. Wildt, S., and Gerngross, T. U. (2005) The humanization of N-glycosylation pathways in yeast. Nat. Rev. Microbiol. 3, 119–128.
152. Wiseman, A. (2004) Double humanized yeast makes hydrocortisone. Trends Biotechnol. 22, 324–325.